^
BCR-ABL1 fusion
ALL
ponatinib
Sensitive
:
A1
Int J Hematol - 1wk
CRLF2 rearrangement
ALL
ruxolitinib
Sensitive
:
C2
Leukemia - 2wk
No biomarker
B Acute Lymphoblastic Leukemia
tisagenlecleucel-T
Sensitive
:
A1
No biomarker
Childhood B Acute Lymphoblastic Leukemia
tisagenlecleucel-T
Sensitive
:
A1
BCR-ABL1 fusion
ALL
imatinib
Sensitive
:
A1
CD22 positive
B Acute Lymphoblastic Leukemia
inotuzumab ozogamicin
Sensitive
:
A1
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
inotuzumab ozogamicin
Sensitive
:
A1
BCR-ABL1 T315I
ALL
ponatinib
Sensitive
:
A1
No biomarker
ALL
blinatumomab
Sensitive
:
A1
No biomarker
B Acute Lymphoblastic Leukemia
blinatumomab
Sensitive
:
A1
No biomarker
T Acute Lymphoblastic Leukemia
nelarabine
Sensitive
:
A1
BCR-ABL1 fusion
ALL
dasatinib
Sensitive
:
A1
CD19 positive
ALL
blinatumomab
Sensitive
:
A1
No biomarker
ALL
mercaptopurine
Sensitive
:
A1
No biomarker
Childhood B Acute Lymphoblastic Leukemia
blinatumomab
Sensitive
:
A1
CD19 positive
B Acute Lymphoblastic Leukemia
blinatumomab
Sensitive
:
A1
No biomarker
B Acute Lymphoblastic Leukemia
inotuzumab ozogamicin
Sensitive
:
A1
BCR-ABL1 V299L
ALL
dasatinib
Resistant
:
A2
BCR-ABL1 F317I
ALL
dasatinib
Resistant
:
A2
BCR-ABL1 T315I
ALL
dasatinib
Resistant
:
A2
BCR-ABL1 fusion
ALL
nilotinib
Sensitive
:
A2
BCR-ABL1 T315I
ALL
bosutinib
Resistant
:
A2
BCR-ABL1 T315I
ALL
nilotinib
Resistant
:
A2
PDGFRA fusion
Childhood B Acute Lymphoblastic Leukemia
dasatinib
Sensitive
:
A2
ABL2 fusion
Childhood B Acute Lymphoblastic Leukemia
dasatinib
Sensitive
:
A2
FGFR fusion
Childhood B Acute Lymphoblastic Leukemia
dasatinib
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our